India Glycols is an API manufacturer based in India. It holds 2 active US drug master files and 2 valid CEPs across a filed portfolio of 3 molecules. Its GMP standing is certified by EMA. Customs aggregates show $26.1M of exports covering 744 molecules to 42 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Dehradun, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Nicotine | US FDA | 2 |
| Colchicine | EDQM | 1 |
| Thiocolchicoside Crystallised From Ethanol | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $6.5M | 23 |
| 2025 | Not reported | $26.1M | 42 |
| 2024 | Not reported | $24.8M | 46 |
| 2023 | Not reported | $41.3M | 46 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. India Glycols comes back tiered against every other supplier able to file there.
Start for free